Regeneron Pharmaceuticals, Inc 10-Q for FY2020 Q2
Regeneron Pharmaceuticals, Inc. (REGN)
10-Q
2020-08-05
For: 2020-06-30
View Original
Added on
April 08, 2026
About this 10-Q
Regeneron Pharmaceuticals, Inc filed this 10-Q on August 5, 2020, covering the quarter ended June 30, 2020 (FY2020 Q2).
Headline figures
Quarter ended June 30, 2020, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $1.95B
- up 23.7% from $1.58B a year earlier
- Net income
- $897.3M
- up 364.7% from net income of $193.1M a year earlier
- Diluted EPS
- $7.61
- up 353.0% from $1.68 a year earlier